Semler Scientific's 'slow money' bitcoin buying strategy should offset diagnostic headwinds, Benchmark says
-
最新报道：Semler Scientific reported Q2 revenue of $8.22M, slightly above estimates, with $66.9M net income driven by an $83.8M unrealized bitcoin gain. The healthtech firm holds 5,021 BTC (cost basis $475.8M) and plans to expand holdings to 10,000 BTC by 2025 using "slow money" strategies like cash flow and selective ATM issuances, avoiding rapid stock dilution. New Bitcoin Strategy Director Joe Burnett emphasized long-term shareholder value. Despite Medicare reimbursement challenges in its core QuantaFlo business, Semler launched CardioVanta SaaS for heart failure detection as a potential cash flow source. Benchmark maintains a $121 price target, though shares fell 2.8% to $34.37 amid a 40% YTD decline.
下一篇
Binance Launches INFINIT Token on Spot and Futures Markets
- Binance debuts INFINIT token with spot and futures listings, airdrop campaign begins Augus...
24小时热点
热点专题
413124